• F3 Tech Advancement Readiness Assessment

    Tell us what you need to accomplish next and what is standing in the way. F3 Tech will use this assessment to determine whether a focused Capability Campaign, Development Residency, extended access, IndBio soft landing, or another F3 Tech pathway is the best fit. We ask for no proprietary information.

  • Your science. Your team. Your milestone.
    Our infrastructure & resources.

    Please use the ARROWS on the right to expand or contract each section.
    Takes about 10 minutes to complete.

    • Company and Contact Information 
    •  - -
    • Number of Employees*
    • Company Stage*
    • Funding Status*
    • Is your project currently supported by an SBIR/STTR or other federal award?
    • Technology Advancement 
    • Primary technology category*
    • Why is this milestone important now? (select all that apply)*
    • What is your target timeframe to achieve this milestone?*
    • Technical Readiness 
    • Has a documented process or protocol been run successfully more than once?*
    • How well are the critical process parameters characterized?*
    • How well is the product/output characterized with analytical data?*
    • Can technical success criteria for the next milestone be defined?*
    • What are the primary technical bottlenecks? (select all that apply)*
    • What technical work is needed next? (select all that apply)*
    • Which best describes the type of F3 Tech access you need right now? (select all that apply)*
    • F3 Tech Capability & Facility Requirements 
    • Which F3 Tech or partner capabilities may be relevant to your project? (select all that apply)*
    • Does your project involve fermentation or bioreactor-based work?*
    • What bioreactor/fermentation scale is relevant to the proposed work?
    • Will the project require or benefit from independent third-party analytical testing or validation in addition to F3 Tech's in-house capabilities?*

    • Qualified third-party resources, including Eurofins when appropriate, can be incorporated into a scoped F3 Tech engagement. Third-party services are optional and separately scoped and priced.

    • What additional analytical or third-party testing may be required?
    • What biosafety level or biological containment level is required for the proposed work, if known?*
    • Does the proposed work involve any of the following? (select all that apply)*
    • Commercial & Validation Readiness 
    • Evidence of market or customer interest*
    • If this milestone is achieved, what is the PRIMARY next step?
    • Target specifications or acceptance criteria defined?*
    • Approximate target economics or cost requirements known?*
    • Likely scale-up or manufacturing pathway identified?*
    • Commercialization support that would be valuable (select all that apply)
    • Execution & Engagement Readiness 
    • Who from your team would be responsible for the engagement?*
    • Can your technical team provide protocols, data, and timely decision-making?*
    • Who do you expect will perform the experimental or development work at F3 Tech?
    • Are the required materials, strains, cell lines, samples, reagents, or other inputs currently available?*
    • Is funding available for the proposed engagement?*
    • What is the approximate project budget range?*
    • When would you ideally like to start?*
    • Will members of your technical team need to work onsite at F3 Tech in Easton, Maryland?*
    • Approximately how many onsite working days do you anticipate needing?
    • Would assistance identifying lower-cost housing or transportation options be useful?
    • Which F3 Tech engagement format currently appears closest to what you need?*
    • How prepared is your organization to authorize and begin a scoped F3 Tech engagement?*
    • IndBio Landing U.S. Market-Entry Readiness 
    • Has your company previously sold, tested, operated, partnered, or maintained a presence in the United States?*
    • What do you hope to accomplish in the United States in the next 6–12 months? (select all that apply)*
    • What U.S. relationships already exist? (select all that apply)
    • Which U.S. regulatory pathway may apply? (select ALL that apply)
    • How developed are your current U.S. relationships?*
    • Evidence of U.S. market demand*
    • Has U.S.-specific regulatory advice been received?*
    • How clearly has your U.S. regulatory pathway been determined?*
    • Would one or more personnel be available to spend time in Maryland?*
    • Approximate number of personnel who might participate
    • Preferred IndBio Landing duration
    • What U.S. market-entry support would be valuable? (select all that apply)
    • Are there known issues involving visas, import/export, biological material shipment, customs, permits, or U.S. entity formation?*
    • Final Information  
  • Should be Empty: